Alexander GC, Emerson S, Kesselheim AS (2021) Evaluation of aducanumab for Alzheimer disease. JAMA. https://doi.org/10.1001/jama.2021.3854

Article  PubMed  PubMed Central  Google Scholar 

Amberger JS, Bocchini CA, Scott AF et al (2019) OMIM.org: leveraging knowledge across phenotype–gene relationships. Nucleic Acids Res 47:D1038–D1043. https://doi.org/10.1093/nar/gky1151

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ayton S, Portbury S, Kalinowski P et al (2021) Regional brain iron associated with deterioration in Alzheimer’s disease: a large cohort study and theoretical significance. Alzheimers Dement 17:1244–1256. https://doi.org/10.1002/alz.12282

Article  PubMed  PubMed Central  Google Scholar 

Bao WD, Pang P, Zhou XT et al (2021) Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer’s disease. Cell Death Differ 28(5):1548–1562. https://doi.org/10.1038/s41418-020-00685-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brosseron F, Maass A, Kleineidam L et al (2023) Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer’s disease: results from the DELCODE study. Alzheimers Res Ther. https://doi.org/10.1186/s13195-022-01118-0

Article  PubMed  PubMed Central  Google Scholar 

Daina A, Michielin O, Zoete V (2019) Swisstargetprediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res 47:W357–W364. https://doi.org/10.1093/nar/gkz382

Article  CAS  PubMed  PubMed Central  Google Scholar 

Damulina A, Pirpamer L, Soellradl M et al (2020) Cross-sectional and longitudinal assessment of brain iron level in Alzheimer Disease Using 3-T MRI. Radiology 296:619–626. https://doi.org/10.1148/radiol.2020192541

Article  PubMed  Google Scholar 

Davis AP, Wiegers TC, Johnson RJ et al (2023) Comparative Toxicogenomics Database (CTD): update 2023. Nucleic Acids Res 51:D1257–D1262. https://doi.org/10.1093/nar/gkac833

Article  CAS  PubMed  PubMed Central  Google Scholar 

Feng L, Sun J, Xia L et al (2024) Ferroptosis mechanism and Alzheimer’s disease. Neural Regen Res 19:1741–1750. https://doi.org/10.4103/1673-5374.389362

Article  CAS  PubMed  Google Scholar 

Fu C, Wu Y, Liu S et al (2022) Rehmannioside A improves cognitive impairment and alleviates ferroptosis via activating PI3K/AKT/Nrf2 and SLC7A11/GPX4 signaling pathway after ischemia. J Ethnopharmacol. https://doi.org/10.1016/j.jep.2022.115021

Article  PubMed  Google Scholar 

Huang X (2023) A concise review on oxidative stress-mediated ferroptosis and cuproptosis in Alzheimer’s disease. Cells. https://doi.org/10.3390/cells12101369

Article  PubMed  PubMed Central  Google Scholar 

Jakaria M, Belaidi AA, Bush AI et al (2021) Ferroptosis as a mechanism of neurodegeneration in Alzheimer’s disease. J Neurochem 159:804–825. https://doi.org/10.1111/jnc.15519

Article  CAS  PubMed  Google Scholar 

Kim EK, Kim JH, Jeong S et al (2019) Pachypodol, a methoxyflavonoid isolated from Pogostemon cablin Bentham exerts antioxidant and cytoprotective effects in HepG2 cells: possible role of ERK-dependent Nrf2 activation. Int J Mol Sci 20(17):4082. https://doi.org/10.3390/ijms20174082

Article  CAS  PubMed  PubMed Central  Google Scholar 

Knox C, Wilson M, Klinger CM et al (2024) DrugBank 6.0: the drugbank knowledgebase for 2024. Nucleic Acids Res 52:D1265–D1275. https://doi.org/10.1093/nar/gkad976

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lai MC, Liu WY, Liou S-S et al (2022) Diosmetin targeted at peroxisome proliferator-activated receptor gamma alleviates advanced glycation end products induced neuronal injury. Nutrients. https://doi.org/10.3390/nu14112248

Article  PubMed  PubMed Central  Google Scholar 

Lei J, Li J, Wu W et al (2025) Neuroprotective effects of Yangming-Kaixin-Yizhi formula in Alzheimer’s disease: dual regulation of PI3K/Akt and p38 MAPK signaling via network pharmacology and experimental approaches. Metab Brain Dis 40(7):254. https://doi.org/10.1007/s11011-025-01688-6

Article  CAS  PubMed  Google Scholar 

Levi S, Ripamonti M, Moro AS et al (2024) Iron imbalance in neurodegeneration. Mol Psychiatry 29:1139–1152. https://doi.org/10.1038/s41380-023-02399-z

Article  PubMed  PubMed Central  Google Scholar 

Li L, Li W-J, Zheng X-R et al (2022) Eriodictyol ameliorates cognitive dysfunction in APP/PS1 mice by inhibiting ferroptosis via vitamin D receptor-mediated Nrf2 activation. Mol Med. https://doi.org/10.1186/s10020-022-00442-3

Article  PubMed  PubMed Central  Google Scholar 

Li N, Duan Y-h, Chen L et al (2023) Iron metabolism: an emerging therapeutic target underlying the anti-Alzheimer’s disease effect of ginseng. J Trace Elem Med Biol. https://doi.org/10.1016/j.jtemb.2023.127252

Article  PubMed  Google Scholar 

Lou Y, Ma M, Jiang Y et al (2022) Ferroptosis: a new strategy for traditional Chinese medicine treatment of stroke. Biomed Pharmacother. https://doi.org/10.1016/j.biopha.2022.113806

Article  PubMed  PubMed Central  Google Scholar 

Ma M, Jing G, Tian Y et al (2025) Ferroptosis in cognitive impairment associated with diabetes and Alzheimer’s disease: mechanistic insights and new therapeutic opportunities. Mol Neurobiol 62(2):2435–2449. https://doi.org/10.1007/s12035-024-04417-9

Article  CAS  PubMed  Google Scholar 

Majerníková N, Marmolejo-Garza A, Salinas CS et al (2024) The link between amyloid β and ferroptosis pathway in Alzheimer’s disease progression. Cell Death Dis. https://doi.org/10.1038/s41419-024-07152-0

Article  PubMed  PubMed Central  Google Scholar 

Mangalmurti A, Lukens JR (2022) How neurons die in Alzheimer’s disease: implications for neuroinflammation. Curr Opin Neurobiol. https://doi.org/10.1016/j.conb.2022.102575

Article  PubMed  PubMed Central  Google Scholar 

Mi Y, Wei C, Sun L et al (2023) Melatonin inhibits ferroptosis and delays age-related cataract by regulating SIRT6/p-Nrf2/GPX4 and SIRT6/NCOA4/FTH1 pathways. Biomed Pharmacother. https://doi.org/10.1016/j.biopha.2022.114048

Article  PubMed  Google Scholar 

Moorthy H, Ramesh M, Padhi D et al (2024) Polycatechols inhibit ferroptosis and modulate tau liquid-liquid phase separation to mitigate Alzheimer’s disease. Mater Horiz 11(13):3082–3089. https://doi.org/10.1039/d4mh00023d

Article  CAS  PubMed  Google Scholar 

Naderi S, Khodagholi F, Pourbadie HG et al (2023) Role of amyloid beta (25–35) neurotoxicity in the ferroptosis and necroptosis as modalities of regulated cell death in Alzheimer’s disease. Neurotoxicology 94:71–86. https://doi.org/10.1016/j.neuro.2022.11.003

Article  CAS  PubMed  Google Scholar 

Piñero J, Ramírez-Anguita JM, Saüch-Pitarch J et al (2019) The disgenet knowledge platform for disease genomics: 2019 update. Nucleic Acids Research. https://doi.org/10.1093/nar/gkz1021

Qiang RR, Xiang Y, Zhang L et al (2024) Ferroptosis: a new strategy for targeting Alzheimer’s disease. Neurochem Int. https://doi.org/10.1016/j.neuint.2024.105773

Article  PubMed  Google Scholar 

Ren F, Wei J, Chen Q et al (2025) Artificial intelligence-drivenmulti-omics approaches in Alzheimer's disease: progress, challenges, and future directions. Acta Pharm Sin B 15(9):4327-4385. https://doi.org/10.1016/j.apsb.2025.07.030

Sanguigno L, Guida N, Anzilotti S et al (2023) Stroke by inducing HDAC9-dependent deacetylation of HIF-1 and Sp1, promotes TfR1 transcription and GPX4 reduction, thus determining ferroptotic neuronal death. Int J Biol Sci 19:2695–2710. https://doi.org/10.7150/ijbs.80735

Article  CAS